These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29301743)

  • 1. Blisters in disguise.
    Dowlatshahi EA; Diercks G; van Doorn M
    BMJ; 2018 Jan; 360():j5364. PubMed ID: 29301743
    [No Abstract]   [Full Text] [Related]  

  • 2. Blistering disease in a child.
    Wong YW; Ratnavel RC; Grabczynska SA
    Clin Exp Dermatol; 2006 May; 31(3):485-6. PubMed ID: 16681624
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-desmoglein antibody-negative paraneoplastic pemphigus successfully treated with rituximab.
    Kanwar AJ; Vinay K; Varma S; Koga H; Ishii N; Hashimoto T
    Int J Dermatol; 2015; 54(5):576-9. PubMed ID: 24738571
    [No Abstract]   [Full Text] [Related]  

  • 4. [Unexpected positive outcome following rituximab treatment in a patient with pemphigus vegetans resistant to conventional therapies: a case report].
    Barbach Y; Baybay H; Mrabat S; Chaouche M; Elloudi S; Mernissi FZ
    Pan Afr Med J; 2019; 32():101. PubMed ID: 31223391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pemphigus herpetiformis].
    Wosnitza M; Blazek C; Megahed M
    Hautarzt; 2008 Jun; 59(6):459-60. PubMed ID: 18470499
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanisms Causing Loss of Keratinocyte Cohesion in Pemphigus.
    Spindler V; Eming R; Schmidt E; Amagai M; Grando S; Jonkman MF; Kowalczyk AP; Müller EJ; Payne AS; Pincelli C; Sinha AA; Sprecher E; Zillikens D; Hertl M; Waschke J
    J Invest Dermatol; 2018 Jan; 138(1):32-37. PubMed ID: 29037765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pemphigus. Guidelines for the diagnosis and treatment. Centres de référence des maladies bulleuses auto-immunes. Société Française de Dermatologie].
    Joly P; Bernard P; Bedane C; Prost C; Ingen-Housz-Oro S;
    Ann Dermatol Venereol; 2011 Mar; 138(3):252-8. PubMed ID: 21397155
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnosis of pemphigus.
    Asboe-Hansen G
    Br J Dermatol; 1970; 83():Suppl:81-92. PubMed ID: 4918295
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pemphigus vulgaris. Clinical aspects, pathophysiology and therapy of a bullous autoimmune dermatosis].
    Sunderkötter CH; Luger TA
    Med Monatsschr Pharm; 1995 Sep; 18(9):255-63. PubMed ID: 7476660
    [No Abstract]   [Full Text] [Related]  

  • 10. IgA pemphigus: the first two Scandinavian cases.
    Gniadecki R; Bygum A; Clemmensen O; Svejgaard E; Ullman S
    Acta Derm Venereol; 2002; 82(6):441-5. PubMed ID: 12575851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pemphigus -- a review.
    Lynch PJ; Gallego RE; Saied NK
    Ariz Med; 1976 Dec; 33(12):1030-7. PubMed ID: 1016077
    [No Abstract]   [Full Text] [Related]  

  • 12. Protective effect of intravenous immunoglobulin (IVIG) in an experimental model of pemphigus vulgaris.
    Mimouni D; Blank M; Ashkenazi L; Milner Y; Frusic-Zlotkin M; Anhalt GJ; David M; Shoenfeld Y
    Clin Exp Immunol; 2005 Dec; 142(3):426-32. PubMed ID: 16297153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and treatment of pemphigus.
    Tsuruta D; Ishii N; Hashimoto T
    Immunotherapy; 2012 Jul; 4(7):735-45. PubMed ID: 22853759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab and Corticosteroid Effect on Desmoglein-Specific B Cells and Desmoglein-Specific T Follicular Helper Cells in Pemphigus.
    Maho-Vaillant M; Perals C; Golinski ML; Hébert V; Caillot F; Mignard C; Riou G; Petit M; Viguier M; Hertl M; Boyer O; Calbo S; Fazilleau N; Joly P
    J Invest Dermatol; 2021 Sep; 141(9):2132-2140.e1. PubMed ID: 33766510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Juvenile pemphigus vulgaris].
    Janisson-Dargaud D; Reguiaï Z; Perceau G; Eschard C; Bernard P
    Ann Dermatol Venereol; 2008 Dec; 135(12):843-7. PubMed ID: 19084695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ["Pemphigus diseases". Nosology, etiopathogenesis and treatment].
    Misgeld V
    Hautarzt; 1973 Sep; 24(9):372-7. PubMed ID: 4588253
    [No Abstract]   [Full Text] [Related]  

  • 17. Pemphigus foliaceus and acquired haemophilia: a rare but important association with life-threatening consequences.
    Wernham AG; Peng C; Bailiff B; Ilchyshyn A
    Clin Exp Dermatol; 2018 Oct; 43(7):825-828. PubMed ID: 29777540
    [No Abstract]   [Full Text] [Related]  

  • 18. Desmoglein ELISA in the diagnosis of pemphigus and its correlation with the severity of pemphigus vulgaris.
    Mortazavi H; Shahdi M; Amirzargar AA; Naraghi ZS; Valikhani M; Daneshpazhooh M; Vasheghani-Farahani A; Sedaghat M; Chams-Davatchi C
    Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):53-6. PubMed ID: 19279360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is novel in the clinical management of pemphigus.
    Bilgic A; Murrell DF
    Expert Rev Clin Pharmacol; 2019 Oct; 12(10):973-980. PubMed ID: 31550941
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of pemphigus in pediatric patients.
    Gürcan H; Mabrouk D; Razzaque Ahmed A
    Minerva Pediatr; 2011 Aug; 63(4):279-91. PubMed ID: 21909064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.